Condition
Fascioscapulohumeral Muscular Dystrophy clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Fascioscapulohumeral Muscular Dystrophy clinical trials that are recruiting, at sites in 17 countries (most in Belgium (1), Czechia (1), Egypt (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 17Countries
All recruiting trials (2)
-
Del-brax (AOC 1020) intravenous treatment for people with FSHD
This study will try regular IV infusions of del-brax (AOC 1020) in adults with FSHD to see if it slows muscle weakness and helps preserve walking ability.
-
Collecting data on muscle disorders using wearable devices
This study is testing a wearable device to track movement in people with muscle disorders like Duchenne Muscular Dystrophy and Myotonic Dystrophy to see how it can help improve their care.
Related topics
Quick answers
How many Fascioscapulohumeral Muscular Dystrophy clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in Belgium (1 trial), Czechia (1 trial), Egypt (1 trial), Hungary (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.